DNA interactions of new antitumor aminophosphine platinum(II) complexes

Molecular Pharmacology

Volumn 56, Issue 1, 1999, Pages 20-30

  Neplechová, Kamila ^a   Kašpárková, Jana ^a   Vrána, OLDŘICH ^a   Nováková, Olga ^a   Habtemariam, Abraha ^b   Watchman, Beth ^b   Sadler, Peter J ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINOPHOSPHINE PLATINUM COMPLEX; ANTINEOPLASTIC AGENT; CISPLATIN; DNA; GUANINE; PHOSPHINE DERIVATIVE; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA CONFORMATION; DNA CROSS LINKING; DNA SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCHEMISTRY; PRIORITY JOURNAL;

EID: 0345161666     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.1.20     Document Type: Article

References (40)

1. +. Mol Pharmacol 53:846-855.
2. Bancroft DP, Lepre CA and Lippard SJ (1990) Pt-195 NMR kinetic and mechanistic studies of cis-diamminedichloroplatinum and trans-diamminedichloroplatinu-m(II) binding to DNA. J Am Chem Soc 112:6860-6871.
3. Bellon SF, Coleman JH and Lippard SJ (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(ii). Biochemistry 30:8026-8035.
4. Berners-Price SJ, Bowen J, McKeage MJ, Galettis P, Ding L, Baguley C and Brower W (1997) Selective antitumour activity of metal complexes of bidentate pyri-dylphosphines. J Inorg Biochem 67:154.
5. Berners-Price SJ and Sadler PJ (1988) Phosphines and metal phosphine complexes: Relationship of chemistry to anticancer and other biological activity. Struct Bonding (Berlin) 70:27-102.
6. Brabec V, Kleinwächter V, Butour JL and Johnson NP (1990) Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. Biophys Chem 35:129-141.
7. Brabec V and Leng M (1993) DNA interstrand cross-links of trans-diamminedichlo-roplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci USA 90:5345-5349.
8. Brabec V and Paleček E (1970) The influence of salts and pH on polarographic currents produced by denatured DNA. Biophysik 6:290-300.
9. Butour JL and Macquet JP (1977) Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe. Eur J Biochem 78:455-463.
10. Chen C, Kilkuskie R and Hanlon S (1981) Circular dichroism spectral properties of covalent complexes of deoxyribonucleic acid and n-butylamine. Biochemistry 20: 4987-4995.
11. Comess KM, Burstyn JN, Essigmann JM and Lippard SJ (1992) Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts. Biochemistry 31:3975-3990.
12. Cullinane C and Phillips DR (1994) Sequence specificity of (cyanomorpholino)adriamycin adducts in human cells. Biochemistry 33:6207-6212.
13. Eastman A (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther 34:155-166.
14. Farrell N, Qu Y, Feng L and Van Houten B (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues. Biochemistry 29:9522-9531.
15. Fichtinger-Schepman AMJ, Van der Veer JL, Den Hartog JHJ, Lohman PHM and Reedijk J (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: Formation, identification, and quantitation. Biochemistry 24:707-713.
16. Gelasco A and Lippard SJ (1998) NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry 37:9230-9239.
17. Gray DM (1996) Circular dichroism of protein-nucleic acid interactions, in Circular Dichroism and The Conformational Analysis of Biomolecules (Fasman GD ed) pp 469-500, Plenum Press, New York.
18. Habtemariam A and Sadler P (1996) Design of chelate ring-opening platinum anti-cancer complexes: Reversible binding to guanine. Chem Commun 1785-1786.
19. Huang HF, Zhu LM, Reid BR, Drobny GP and Hopkins PB (1995) Solution structure of a cisplatin-induced DNA interstrand cross-link. Science (Wash DC) 270:1842-1845.
20. Johnson JW (1996) Determination of the conformation of nucleic acids by electronic CD, in Circular Dichroism and The Conformational Analysis of Biomolecules (Fasman GD ed) pp 433-468, Plenum Press, New York.
21. Johnson NP, Butour J-L, Villani G, Wimmer FL, Defais M, Pierson V and Brabec V (1989) Metal antitumor compounds: The mechanism of action of platinum complexes. Prog Clin Biochem Med 10:1-24.
22. Johnson NP, Macquet JP, Wiebers JL and Monsarrat B (1982) Structures of adducts formed between [Pt(dien)Cl]Cl and DNA in vitro. Nucleic Acids Res 10:5255-5271.
23. Keck MV and Lippard SJ (1992) Unwinding of supercoiled DNA by platinum ethidium and related complexes. J Am Chem Soc 114:3386-3390.
24. Kim SD, Vrána O, Kleinwächter V, Niki K and Brabec V (1990) Polarographic determination of subnanogram quantities of free platinum in reaction mixture with DNA. Anal Lett 23:1505-1518.
25. Konopa J (1983) Adriamycin and daunomycin induce interstrand DNA cross-links in HeLa S3 cells. Biochem Biophys Res Commun 110:819-826.
26. Margiotta N, Habtemariam A and Sadler PJ (1997) Strong, rapid binding of a platinum complex to thymine and uracil under physiological conditions. Angew Chem Int Ed Engl 36:1185-1187.
27. Murray V, Motyka H, England PR, Wickham G, Lee HH, Denny WA and McFadyen WD (1992) The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or 2 analogues. J Biol Chem 267:18805-18809.
28. Nováková O, Kašpárková J, Vrána O, van Vliet PM, Reedjjk J and Brabec V (1995) Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes. Biochemistry 34:12369-12378.
29. 6. J Chem Soc Dalton Trans 3435-3443.
30. Pérez-Martin JM, Requena JM, Craciunescu D, López MC and Alonso C (1993) The anti Z-DNA reactivity of Z-DNA forming sequences is affected by platinum anti-tumor drugs. J Biol Chem 268:24774-24779.
31. Reeder F, Guo ZJ, Murdoch PD, Corazza A, Hambley TW, BernersPrice SJ, Chottard JC and Sadler PJ (1997) Platination of a GG site on single-stranded and double-stranded forms of a 14-base oligonucleotide with diaqua cisplatin followed by NMR and HPLC - Influence of the platinum ligands and base sequence on 5′-G versus 3′-G platination selectivity. Eur J Biochem 249:370-382.
32. Reedijk J (1996) Improved understanding in platinum antitumour chemistry. Chem Commun 801-806.
33. Sundquist WI, Lippard SJ and Stollar BD (1987) Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). Proc Natl Acad Sci USA 84:8225-8229.
34. Ushay HM, Santella RM, Caradonna JP, Grunberger D and Lippard SJ (1982) Binding of [(dien)PtCl]Cl to poly(dG-dC).poly(dG-dC) facilitates the B->Z conformational transition. Nucleic Acids Res 10:3573-3588.
35. Vrána O, Boudný V and Brabec V (1996) Superhelical torsion controls DNA interstrand cross-linking by antitumor cis-diamminedichloroplatinum(II). Nucleic Acids Res 24:3918-3925.
36. Vrána O, Brabec V and Kleinwächter V (1986) Polarographic studies on the conformation of some platinum complexes: Relations to antitumour activity. Anti-Cancer Drug Des 1:95-109.
37. Vrána O, Kiseleva VI, Poverenny AM and Brabec V (1992) Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II)-immunochemical analysis. Eur J Pharmacol 226:5-13.
38. 3)(quinoline)]. Eur J Biochem 254: 547-557.
39. 2] on B→Z transition in DNA. Anticancer Drug Des 12:295-309.
40. 2]. Mol Pharmacol 52:354-361.